Clinical Trial: Evaluate the Safety and Efficacy of HL-1186 Tablet for Moderate to Severe Acute Pain After Surgery

U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07147049) titled 'Evaluate the Safety and Efficacy of HL-1186 Tablet for Moderate to Severe Acute Pain After Surgery' on Aug. 11.

Brief Summary: This is a multiple-center, randomized, double-blind, placebo-controlled study design evaluating the safety, efficacy, and PK parameter of HL-1186 tablet for moderate to severe acute pain after surgery.

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Moderate to Severe Acute Postoperative Pain

Intervention: DRUG: HL-1186

HL-1186 tablet for oral administration.

DRUG: HL-1186 placebo

HL-1186 placebo tablet for oral administration.

Recruitment Status: RECRUITING

Sponsor: Shanghai Yi...